Company Filing History:
Years Active: 2023
Title: Innovations of Yangcheng Qiu in Hubei, China
Introduction
Yangcheng Qiu is a notable inventor based in Hubei, China. He has made significant contributions to the field of chemistry, particularly in the development of new heterocyclic compounds. His work focuses on creating innovative solutions that can have a substantial impact on various applications.
Latest Patents
Yangcheng Qiu holds a patent for "Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors." This invention provides new heterocyclic compounds characterized by a general formula (Ie), where R, R, and R are defined in the patent. The patent also includes compositions that incorporate these compounds, processes for manufacturing them, and methods for their use. He has 1 patent to his name.
Career Highlights
Yangcheng Qiu is associated with Hoffmann-La Roche Inc., a leading global healthcare company. His role at the company allows him to engage in cutting-edge research and development, contributing to advancements in pharmaceutical sciences.
Collaborations
He has collaborated with notable colleagues, including Ann Petersen and Joerg Benz. These partnerships enhance the innovative potential of his work and foster a collaborative environment for research.
Conclusion
Yangcheng Qiu's contributions to the field of chemistry and his innovative patent demonstrate his commitment to advancing scientific knowledge. His work at Hoffmann-La Roche Inc. and collaborations with esteemed colleagues further highlight his impact in the industry.